Chemo Mouthpiece, LLC specializes in developing an innovative cryotherapy device designed to alleviate the symptoms of chemotherapy-related oral mucositis, a painful and debilitating condition affecting cancer patients. The device, known as 'The Chemo,' is composed of medical-grade silicone, fresh water, and a proprietary saline solution. It features a dual-chamber design where the inner chamber, filled with fresh water, freezes solid, while the outer chamber, filled with saline solution, remains extremely cold without freezing solid. This design ensures uniform cooling of the entire oral cavity, making it more effective and tolerable than traditional ice chips.

The company primarily serves cancer patients undergoing chemotherapy, providing a more efficient and comfortable solution to oral mucositis. Operating in the healthcare and medical device market, Chemo Mouthpiece, LLC follows a business-to-consumer (B2C) model, selling its product directly to patients and healthcare providers. Revenue is generated through direct sales of the device and potential licensing of its patented technology.

The Chemo Mouthpiece has been recognized by leading cancer care organizations such as NCCN, MASCC, and ONS for its effectiveness in reducing oral mucositis. The company has filed for numerous patents globally, with several already granted, ensuring a strong intellectual property position.

Keywords: cryotherapy, oral mucositis, chemotherapy, cancer care, medical device, patient comfort, healthcare innovation, dual-chamber design, patent-protected, B2C.